Business Wire

WA-LUMITHERA

Share
LumiThera Announces First CPT Code to Report Photobiomodulation Therapy in Retinal Disease – First Step Toward Reimbursement

LumiThera, Inc., a medical device company commercializing a photobiomodulation (PBM) treatment for ocular damage and disease, today announced a new Category III CPT code effective January 1, 2025. The AMA’s CPT Editorial Panel considered and approved the company’s application for a code to report “Photobiomodulation therapy of retina, single session” at the May 2024 meeting.1

Support for this new Category III code came from many sources; one was LumiThera’s clinical trial. LIGHTSITE III was a prospective, double-masked, randomized, sham-controlled, parallel group, multi-center clinical trial conducted at ten leading US retinal centers. The purpose was to assess the safety and efficacy of photobiomodulation treatment in patients with dry age-related macular degeneration (AMD). The primary efficacy endpoint, best corrected visual acuity (BCVA), was evaluated at 13 months and was significantly improved (p < 0.025). The trial continued for a total 24 months. The 24-month data showed minimal safety risks and high patient compliance with over 80% of the patients completing the six rounds of Valeda PBM treatment sessions.

The analysis included 91 eyes in the PBM treatment group and 54 eyes in the sham-treatment group in the modified intent to treat population with at least 1 post-treatment visit and disease consistent with early/intermediate dry AMD. The results demonstrated statistically significant improvement in the primary endpoint in BCVA at 13 months in the PBM treatment group over the sham-treatment group (p < 0.025). A mean increase in ETDRS letter score of >5.0 letters from baseline was seen at both the 13- and 21-month timepoints in the PBM-treated subjects' BCVA (p < 0.0001). Less patients progressed to new geographic atrophy, a later stage scar that is seen with the permanent loss of retinal tissue.

“Establishing a unique CPT code for PBM use in retina is a positive step toward reimbursement,” stated Kevin J. Corcoran. Kevin is a Principal for Corcoran & Corcoran, a leading advisor on reimbursement for ophthalmic products and services. He said, “Not every application for a new CPT code is successful. Those that succeed, like this one, have support from the professional societies as well as evidence-based medicine published in the scientific literature.”

“In parallel with our De Novo submission to the FDA, this is another important step for dry AMD patients experiencing vision loss who currently have limited treatment options. LumiThera wants patients to have access to non-invasive Valeda treatments to improve vision and address the disease earlier in the process,” stated Clark Tedford, Ph.D., LumiThera President and CEO.

About AMD

AMD is a leading cause of vision loss for people aged 65 and older. Losing central vision can make it harder to see faces, drive, or do close-up work like cooking or fixing things around the house. The overall prevalence of AMD is estimated to increase 7-fold with age, from 4.2% in those aged 45–49 years, to 27.2% in those aged 80–85 years. Globally, the prevalence is estimated to increase by 20% between 2020 (195.6 million) and 2030 (243.3 million).

About LumiThera

LumiThera, Inc. is a medical device company focused on diagnosing, treating, and monitoring ocular disease and damage including dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 65.

LumiThera’s flagship product, the Valeda® Light Delivery System, uses multiwavelength photobiomodulation to treat dry AMD patients. Valeda is CE Marked in the EU and is available in select countries in Latin America. Valeda is not cleared by the Food and Drug Administration (FDA).

AdaptDx Pro® dark adaptation functional testing technology enables eye care professionals to detect and monitor AMD three years before clinical presentation. AdaptDx Pro is available in the US and Canada.

Diopsys ERG and VEP systems help eye care professionals analyze the entire pathway for visual and neuro-visual disorders. VEP is available in the USA and select countries outside the USA. ERG is only available outside of the USA.

LumiThera’s AMD Excellence Program® provides customer implementation, training, best practices, and ongoing support across all brands.

For more information on the Valeda® Light Delivery System please visit www.lumithera.com. The AdaptDx Pro and Diopsys ERG and VEP systems are available separately through LumiThera Diagnostics, Inc. and Diopsys, Inc.

___________________

1 AMA. Summary of action of CPT Editorial Panel. https://www.ama-assn.org/system/files/may-2024-summary-of-panel-actions.pdf Accessed 8/6/24

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240807248314/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SIAL Innovation Awards Prize Winners 202411.10.2024 17:27:00 CEST | Press release

SIAL Innovation is a global food innovation observatory, run in partnership with ProtéinesXTC, that reviews thousands of applications submitted by the show’s exhibitors every two years. Through SIAL Innovation, SIAL Paris recognises these innovations through about twenty theme-based awards allocated by category (dairy, seafood, frozen food, etc.), as well as special awards like the Own the Change (CSR) Awards, the Start-up Awards, and the Public’s Choice Awards for which the SIAL Paris ecosystem is invited to vote before and during the show. This 2024 edition features new special prizes such as the Top 3 Countries Awards, for the pick of the nations that have offered the most innovative products, and the Africa Awards. SIAL Paris is a trendsetter and offers visitors a unique insight into the future of global food through a dedicated area at the show featuring products from the SIAL Innovation selection. INNOVATION BOOSTED IN 2024 Quality and quantity: the SIAL Innovation 2024 Awards sh

Datos Insights Recognizes Laserfiche Customer Stonehage Fleming with 2024 Impact Award for Technology Transformation11.10.2024 16:00:00 CEST | Press release

Laserfiche — the leading SaaS provider of intelligent content management and business process automation — today announced that its customer, Stonehage Fleming, has won the Datos Insights 2024 Digital Wealth Management Impact Award for Technology Transformation. This award recognizes Stonehage Fleming’s innovation in leveraging Laserfiche’s suite of content management, process automation, integration, information governance and intelligent data capture tools to drive operational excellence across the organization. Stonehage Fleming, a leading international provider of wealth management and fiduciary services, addressed a number of challenges with its transformation, including inefficient legacy systems, increasing regulatory complexity, and meeting evolving client needs. To achieve its digital initiatives, the IT team adopted Laserfiche as a process orchestration engine across its 19 global offices. The team automated various legacy processes in the Business Development department whic

Oakio Concludes Successful Participation at Batimat Paris 202411.10.2024 15:30:00 CEST | Press release

Oakio has successfully concluded its participation in Batimat 2024, held in Paris from September 30th to October 3rd. The event provided a valuable platform to showcase a range of innovative Wood-Plastic Composite (WPC) solutions, while also facilitating connections with industry professionals from across the globe. Highlighting Innovation and Sustainability At Batimat, Oakio presented its latest range of sustainable building materials, including decking, cladding, fencing, beam, and pergolas. These WPC products are crafted from a blend of recycled oak wood fibers and high-density polyethylene, offering superior durability, weather resistance, and low maintenance. The Elashield decking, recognized for its advanced slip resistance, attracted attention for its use in poolside and high-traffic areas. The Armstrong WPC pergola and Proshield WPC beam, with their enhanced protection against moisture, UV rays, and staining, also drew significant interest for their aesthetic appeal and long-la

European DataWarehouse Presents 3rd Annual Data Quality Awards11.10.2024 13:59:00 CEST | Press release

European DataWarehouse (EDW) presented its third annual Data Quality Awards today at the 2024 TSI Congress in Berlin. This year EDW the annual Best Data Quality – Deal of the Year (2023-2024), award to Domivest B.V. for their deal, Domi 2023-1 B.V. "We are incredibly proud to receive this year's 'Best Data Quality – Deal of the Year' award from European DataWarehouse. Our team is dedicated to upholding top-tier data quality in its reporting, and EDW's tools play a key role in helping us maintain those high standards,” said Josja Reek, CFO at Domivest. The award program was founded in 2022 and was first presented at EDW’s 10th anniversary celebration in Frankfurt. The award program recognises exceptional effort and superior data quality from ABS issuers and their servicers. While presenting the award EDW’s CEO, Dr. Christian Thun, remarked, "EDW's award program gives us a chance to recognize the critical role of data quality and express our gratitude to our issuers for their meticulous

Vecima Acquires Falcon V Systems, Provider of Innovative Software Orchestration Platform for Cable, Fiber, and Mobile Access Networks11.10.2024 13:30:00 CEST | Press release

Combination of Vecima’s Entra Cloud™ and Falcon’s Principal Core and Test Suite will help operators accelerate and simplify cable, fiber, and mobile access network and service flow convergence, using automated software tools and testing Charter Communications will be the initial customer, signing a multi-year deal to deploy both the Principal Core and Test Suite Falcon V Systems’ open, interoperable platform supports multiple vendors’ vCMTS platforms, including Vecima’s Entra® vCMTS & Entra® vPON Manager Vecima Networks, Inc. (TSX: VCM) today announced that, through its subsidiary Vecima Technology B.V., it has acquired Falcon V Systems, a Poland-based provider of vendor-agnostic, virtualized software solutions and services for Broadband Service Providers worldwide. Vecima has acquired all outstanding Falcon V Systems shares, as well as the company’s technology, intellectual property, and talent. With the close of the acquisition today, Vecima will onboard a significant portion of the

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye